IX Biopharma seeks SGX-ST trading halt lift for shares in Singapore
Reuters2026/09/06 23:31- IX Biopharma submitted a request to lift its trading halt on the SGX-ST.
- The halt covered IX Biopharma Ltd. (ISIN SG1BD9000009; stock code 42C) and related securities on SGX-ST.
- The request took effect at 8:30 a.m. Singapore time on Sept. 7, 2026.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Goldman Sachs remains bullish on the South Korean stock market: Driven by the AI memory boom, with a potential upside of up to 80%.
Goldman Sachs strategist Timothy Moe maintains his bullish target on the South Korean stock market, believing that investors are underestimating how long the benefits of artificial intelligence (AI) will last for the country's memory chip manufacturers.
Oranjebtc cancels 25 million treasury shares without capital reduction
The Last Time Treasury Yields Hit 6%, Bitcoin Didn't Exist — What Happens If They Get There Again?
Crypto prices
More
